Kade Grzegorz, Lubas Arkadiusz, Bodnar Lubomir, Szczylik Cezary, Wańkowicz Zofia
Department of Internal Disease, Nephrology and Dialysis Therapy, Central Clinical Hospital, Ministry of the Interior and Administration, Military Institute of Medicine, Warsaw, Poland.
Contemp Oncol (Pozn). 2012;16(5):382-7. doi: 10.5114/wo.2012.31765. Epub 2012 Nov 20.
In 1975 Matas and co-workers were the first in the world literature to show an increased risk of malignant tumor occurrence in the group of hemodialyzed patients and kidney transplant recipients. The report is an analysis of world literature from the last 35 years in reference to epidemiology as well as the profile of screening tests and diagnostic methods related to malignant tumors in the population with end stage renal disease, especially hemodialyzed patients.
1975年,马塔斯及其同事在世界文献中首次表明,血液透析患者和肾移植受者群体中发生恶性肿瘤的风险增加。该报告分析了过去35年的世界文献,内容涉及终末期肾病患者,尤其是血液透析患者中与恶性肿瘤相关的流行病学、筛查测试概况及诊断方法。